Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02200263 · ClinicalTrials.gov registry record · NA
The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02200263: Completed NA study, sponsored by Johns Hopkins University.
NCT02200263 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02200263, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The LUVIA study is a randomized placebo-controlled trial designed to investigate the effects of lutein and zeaxanthin supplementation on macular pigment and visual function in ocular or oculocutaneous albinism. Lutein and zeaxanthin supplementation will be compared to a placebo (no treatment) gel pill over the period of 12 months, with study visits approximately every 3 months for the first year and a final visit 18 months after enrollment.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Lutein plus Zeaxanthin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-11 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02200263
The ClinicalTrials.gov registry entry for NCT02200263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02200263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02200263 about?
NCT02200263 is a clinical study titled "The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism". The LUVIA study is a randomized placebo-controlled trial designed to investigate the effects of lutein and zeaxanthin supplementation on macular pigment and visual function in ocular or oculocutaneous albinism. Lutein and zeaxanthin supplementation will be compared to a placebo (no treatment) gel pi...
What is the current status of trial NCT02200263?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-11. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02200263?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Lutein plus Zeaxanthin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02200263?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.